Zolmitriptan Patent Expiration
Zolmitriptan was first introduced by Ipr Pharmaceuticals Inc
Zolmitriptan Patents
Given below is the list of patents protecting Zolmitriptan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zomig |
US6750237 (Pediatric) | Pharmaceutical formulations containing zolmitriptan |
May 28, 2021
(Expired) | Amneal |
| Zomig |
US7220767 (Pediatric) | Pharmaceutical formulations containing zolmitriptan |
May 28, 2021
(Expired) | Amneal |
| Zomig | US6750237 | Pharmaceutical formulations containing zolmitriptan |
Nov 28, 2020
(Expired) | Amneal |
| Zomig | US7220767 | Pharmaceutical formulations containing zolmitriptan |
Nov 28, 2020
(Expired) | Amneal |
| Zomig |
US5466699 (Pediatric) | Indolyl compounds for treating migraine |
May 14, 2013
(Expired) | Amneal |
| Zomig |
US5466699 (Pediatric) | Indolyl compounds for treating migraine |
May 14, 2013
(Expired) | Ipr |
| Zomig |
US5863935 (Pediatric) | Therapeutic heterocyclic compounds |
May 14, 2013
(Expired) | Ipr |
| Zomig-zmt |
US5466699 (Pediatric) | Indolyl compounds for treating migraine |
May 14, 2013
(Expired) | Astrazeneca |
| Zomig | US5466699 | Indolyl compounds for treating migraine |
Nov 14, 2012
(Expired) | Amneal |
| Zomig | US5466699 | Indolyl compounds for treating migraine |
Nov 14, 2012
(Expired) | Ipr |
| Zomig | US5863935 | Therapeutic heterocyclic compounds |
Nov 14, 2012
(Expired) | Ipr |
| Zomig-zmt | US5466699 | Indolyl compounds for treating migraine |
Nov 14, 2012
(Expired) | Astrazeneca |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Zolmitriptan's patents.
Latest Legal Activities on Zolmitriptan's Patents
Given below is the list recent legal activities going on the following patents of Zolmitriptan.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Nov, 2018 | US7220767(Litigated) |
| Request for Trial Denied Critical
| 02 Feb, 2016 | US7220767(Litigated) |
| Request for Trial Denied Critical
| 27 Jan, 2016 | US6750237(Litigated) |
| Recordation of Patent Grant Mailed Critical
| 22 May, 2007 | US7220767(Litigated) |
| Patent Issue Date Used in PTA Calculation Critical
| 22 May, 2007 | US7220767(Litigated) |
| Issue Notification Mailed Critical
| 02 May, 2007 | US7220767(Litigated) |
| Dispatch to FDC | 19 Apr, 2007 | US7220767(Litigated) |
| Issue Fee Payment Received Critical
| 18 Apr, 2007 | US7220767(Litigated) |
| Application Is Considered Ready for Issue Critical
| 18 Apr, 2007 | US7220767(Litigated) |
| Issue Fee Payment Verified Critical
| 18 Apr, 2007 | US7220767(Litigated) |
Zolmitriptan's Family Patents
